Pharma Capital
Showing 40 of 885
Name Market Market Cap Share Price Daily Share Movement
1300 SMILES LIMITED ASX £93.66m £4.40 -0.41% ico_glass.png
1ST DENTAL LABS PRIVATE £- £- - ico_glass.png
4D Pharma AIM £283.35m £4.37 -1.83% ico_glass.png
Abbvie NYSE £- £- - ico_glass.png
Abcam AIM £1,671.70m £8.21 -1.97% ico_glass.png
Abeona Therapeutics NASDAQ £- £- - ico_glass.png
ABIOMED NASDAQ £- £- - ico_glass.png
abzena-logo.png Abzena plc AIM £51.69m £0.38 -1.32% ico_glass.png
Accelrys NASDAQ £- £- - ico_glass.png
Accurexa OTCBB £- £- - ico_glass.png
AcelRx Pharmaceuticals NASDAQ £- £- - ico_glass.png
Achillion Pharmaceuticals NASDAQ £- £- - ico_glass.png
Acrux ASX £28.27m £0.17 -3.45% ico_glass.png
Actinogen Medical ASX £23.91m £0.04 3.17% ico_glass.png
Adherium ASX £18.78m £0.11 0.00% ico_glass.png
ahz[LOGO]200x100.jpg Admedus Ltd ASX £51.75m £0.20 0.00% ico_glass.png
Advanced Medical Solutions Group AIM £523.03m £2.49 1.84% ico_glass.png
Advanced-Oncotherapy-logo.png Advanced Oncotherapy AIM £20.71m £0.29 -8.06% ico_glass.png
Advanced Surgical Design & Manufacturing ASX £16.41m £0.22 12.12% ico_glass.png
Aetna NYSE £- £- - ico_glass.png
Affymax NASDAQ £- £- - ico_glass.png
AFP Imaging OTCMKTS £- £- - ico_glass.png
Agenix Limited ASX £- £- - ico_glass.png
Agenus NASDAQ £- £- - ico_glass.png
Agility Health TSX-V £- £- - ico_glass.png
Agios Pharmaceuticals NASDAQ £- £- - ico_glass.png
AGTC NASDAQ £- £- - ico_glass.png
Ainsworth Lumber TSX £- £- - ico_glass.png
AirXpanders ASX £51.43m £0.54 2.89% ico_glass.png
akers.png Akers Biosciences, Inc. AIM £11.23m £1.55 31.91% ico_glass.png
Akorn NASDAQ £- £- - ico_glass.png
Al Noor Hospitals Group LSE £- £- - ico_glass.png
Alchemia ASX £2.56m £0.01 18.18% ico_glass.png
Alcidion Group ASX £24.85m £0.04 -2.86% ico_glass.png
Alda Pharmaceuticals TSX-V £- £- - ico_glass.png
ALEGRO HEALTH CORP TSX-V £- £- - ico_glass.png
Alere NYSE £- £- - ico_glass.png
Alkermes NASDAQ £- £- - ico_glass.png
Allergan NYSE £- £- - ico_glass.png
allergytherap.gif Allergy Therapeutics plc AIM £142.43m £0.24 -2.54% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.